Diabetes significantly increases women's long-term risk for dying after a heart attack

August 01, 2001

BOSTON--Women who have diabetes have a substantially greater risk of dying a few years after suffering a heart attack than do non-diabetic women, according to a study led by researchers at Beth Israel Deaconess Medical Center. The findings are published in the August issue of Diabetes Care, a peer-reviewed journal of the American Diabetes Association. In a prospective study of 1,935 men and women who had been hospitalized for a heart attack, the researchers found that the long-term mortality rate for women with diabetes was almost three times greater than the rate for women without diabetes. The long-term mortality rate for all people with diabetes was nearly twice that for non-diabetic people.

"Our findings confirm that diabetes markedly raises the long-term death rate of people with heart attacks, especially women," says Kenneth J. Mukamal, M.D., M.P.H., an associate physician at Beth Israel Deaconess and lead author of the study. "In light of this, diabetic patients need aggressive treatment of cardiac risk factors to prevent heart attacks, and people without diabetes should emphasize healthy lifestyle choices that may prevent diabetes, including proper diet and exercise."

Recent studies have shown that having diabetes increases a person's risk of long-term mortality after suffering a heart attack, but the findings had limitations. Many of the studies' post-heart attack follow-up periods lasted 12 or fewer months and most could not control for lifestyle characteristics that differ between diabetic and non-diabetic patients and may impact mortality.

In this latest study, Mukamal and his colleagues analyzed data collected through medical records reviews and face-to-face interviews with participants enrolled in the Determinants of Myocardial Infarction Onset Study. The researchers followed the participants for an average of 3.7 years after they were hospitalized for a heart attack. They also measured for a variety of lifestyle and sociodemographic factors that could distort the mortality rate, such as usual frequency of physical exertion, alcohol consumption and education attainment.

Approximately 21 percent (399) of the participants had clinically diagnosed diabetes. Twenty nine percent (116) of the diabetic participants died during the follow-up period. In comparison, 13 percent (204) of the non-diabetic participants died.

The researchers found that the long-term mortality rate for diabetic participants who survived an initial heart attack was equivalent to the rate for people who had survived a second heart attack. Previous studies have shown that diabetes and a heart attack adversely impact the heart, especially the left ventricle, in a similar manner. This could be one explanation for the comparable long-term mortality rates.

However, the researchers did not find any relationship between the length of time a participant had been diagnosed with diabetes and the risk of long-term mortality after suffering a heart attack. In addition, the type of treatment participants used to control their diabetes - insulin, oral medication or diet - did not have an impact on the mortality rate.

Mukamal says that based on their findings, he and his colleagues believe that care strategies that focus on the short-term prognosis of diabetic patients who have had a heart attack are insufficient. "It is clear that there is an immediate need for more research on specialized primary and secondary prevention strategies for diabetic patients," says Mukamal, who is also an instructor in medicine at Harvard Medical School. "Developing specialized strategies for caring for diabetic patients, such as screenings for coronary heart disease or the preferential use of bypass surgery for revascularization, may greatly improve their health and their overall quality of life."
-end-
The study's other authors are Richard W. Nesto, M.D., Lahey Clinic Medical Center, Mylan C. Cohen M.D., M.P.H., Maine Medical Center, James E. Muller, M.D., Massachusetts General Hospital, Malcolm McClure, Sc.D., Harvard School of Public Health, and Murray A. Mittleman, M.D., Dr.P.H., Beth Israel Deaconess. The study was funded by the National Heart, Lung and Blood Institute, the National Institute on Alcohol Abuse and Alcoholism and the American Heart Association.

Beth Israel Deaconess Medical Center is a major patient care, research and teaching affiliate of Harvard Medical School and a founding member of CareGroup Healthcare System. Beth Israel Deaconess is the fourth largest recipient of National Institutes of Health research funding among independent U.S. teaching hospitals.

Beth Israel Deaconess Medical Center

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.